Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
AGI Biopharmaceuticals
company
About
AGI Biopharmaceuticals offers a patented melanoma vaccine with future multi-cancer applications.
- 11 - 50
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $4.71M
- Industries
- Biopharma,Biotechnology,Health Care,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 2009
- Number Of Employee
- 11 - 50
- Operating Status
- Active
AGI Biopharmaceuticals, Ltd., a European firm that has developed a patented, economic, melanoma vaccine with future multi-cancer application.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$4.71M
AGI Biopharmaceuticals has raised a total of
$4.71M
in funding over 2 rounds. Their latest funding was raised on
Nov 28, 2011 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 28, 2011 | Series Unknown | $4.71M | 1 |
Mentor Capital Partners
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
AGI Biopharmaceuticals is funded by 1 investors.
Mentor Capital Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Mentor Capital Partners
|
Yes | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
